Potential role of cyanidin 3-glucoside (C3G) in diabetic cardiomyopathy in diabetic rats: An in vivo approach  by Li, Weizhen et al.
Saudi Journal of Biological Sciences (2016) xxx, xxx–xxxKing Saud University
Saudi Journal of Biological Sciences
www.ksu.edu.sa
www.sciencedirect.comORIGINAL ARTICLEPotential role of cyanidin 3-glucoside (C3G) in
diabetic cardiomyopathy in diabetic rats: An in vivo
approach* Corresponding authors. Fax: +86 21 38804518 (L. Zhong), Fax:
+86 21 6324 0090 (S. Liu).
E-mail addresses: llwq979330@163.com (L. Zhong), shaowenliu@
hotmail.com (S. Liu).
Peer review under responsibility of King Saud University.
Production and hosting by Elsevier
http://dx.doi.org/10.1016/j.sjbs.2016.11.007
1319-562X  2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Please cite this article in press as: Li, W. et al., Potential role of cyanidin 3-glucoside (C3G) in diabetic cardiomyopathy in diabetic rats: An in vivo approac
Journal of Biological Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.11.007Weizhen Li a, Songwen Chen a, Genqing Zhou a, Hongli Li a, Lan Zhong b,*,
Shaowen Liu a,*aDepartment of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 20080,
China
bDivision of Gastroenterology, East Hospital of Tongji University School of Medicine, Shanghai 200120, ChinaReceived 17 September 2016; revised 29 October 2016; accepted 4 November 2016KEYWORDS
Cyanidin 3-glucoside;
Cardiomyopathy;
Immuno histochemistry;
Western blotAbstract The present study aimed to evaluate the importance of cyanidin 3-glucoside (C3G) of
diabetic cardiomyopathy in diabetic rats. The rats were induced with diabetic using streptozotocin
and total triglyceride (TG) and total cholesterol (TC) were determined. The range of myocardial
enzymes such as aspartate aminotransferase (AST), creatine kinase (CK) and lactate dehydrogenase
(LD) were also estimated, further, the Immuno histochemical analysis and western blot investiga-
tion were determined for the actual activity of C3G. Results indicated that the marker enzymes such
as CK, LD and AST were significantly (P< 0.05) increased in STZ administered rats (DM group),
while the levels of these elevated marker enzymes of cardiac injury significantly (P< 0.05) declined
in the DM+ C3G group, as compared to the diabetic group of rats. Additionally, a decrease in the
level of TNF-alpha and interleukin-6, was noticed in the C3G treated group as compared to dia-
betic group. Finally, blotting analysis clearly confirmed that theC3G treatment resulted to higher
level response of Bcl-2 and lower level response of caspase-3 and BAX. In conclusion, C3G a nat-
ural antioxidant may prevent cardiovascular complications by ameliorating oxidative damage,
inflammation, metabolic dysfunctions and apoptosis pathways in type 2 diabetes.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Globally, diabetes mellitus (DM) is a fast growing serious dis-
ease specifically in adult with prevalence of 135 million in the
year 1995, with the expected prevalence of 300 million in 2025
(Kaul et al., 2012). DM causes above 80% of deaths in middle
income countries. In 2030, DM will be the seventh foremost
reason for death as per WHO projection (Mathers andh. Saudi
2 W. Li et al.Loncar, 2006). Diabetic cardiomyopathy (DCM) is a critical
coronary heart disease in the diabetes mellitus type-2
(Ernande et al., 2011). It is actually seen as a heart dysfunction
a result of structural and functional changes in myocardium
thereby leading to congestive heart failure (Ernande et al.,
2011).
Pro-inflammatory expression is usually suggested as factor in
the development of diabetic cardiomyopathy (Varga et al., 2015;
Antonisamy et al., 2015). It is widely accepted that cytokines viz.
TNF-a, interleukin-6 and interleukin-1beta are documented to
producemyocardial injury (Boudina andAbel, 2010). Theman-
ifestation of cardiac inflammatory markers viz. TNF-a,
interleukin-6 and interleukin-1beta are implicated in DCM
(Zeybek et al., 2011). Nevertheless, the underlying mechanism
in the progression of DCM is still inadequately elucidated.
Numerous preclinical studies demonstrated that nutritional
diets rich with high anthocyanin extracts improve hyper-
glycemia as well as hyperlipidemia by improved insulin sensitiv-
ity in high-fructose fed rats (Priscilla et al., 2015) and
investigational type 2 diabetic animals (Tahara et al., 2011;
Balamurugan, 2015; Rathi et al., 2015; Nandhini and Stella
Bai, 2015; Kalaiselvi et al., 2016). The findings of such studies
indicate that anthocyanins might have significant effects to pre-
vent obesity and type 2 diabetes (Guo and Ling, 2015).
Various reports exhibited that anthocyanins possess the
strong anti-inflammatory action, and down-turn of
interleukin-6, TNF-a and MCP-1 can lead to improvement
of insulin resistance (Jayaprakasam et al., 2005). Furthermore,
recent studies have proven that dietary intake of phytochemi-
cals rich in cyanidin 3-glucoside is significantly associated with
enhanced insulin sensitivity in the experimental model of insu-
lin resistance (Guo et al., 2012; Neelamkavil and Thoppil,
2016; Valsan and Raphael, 2016). Cyanidin-3-glucoside
(C3G) is a plant pigment which belongs to anthocyanin family,
which abundantly occurs in edible berries, colored fruits and
flowers (Sri Harsha et al., 2013). It is also a polyphenolic flavo-
noid that exerts strong anti-inflammatory and anti-oxidant,
been confirmed in various studies in both the experiments
in vitro and in vivo (Huang et al., 2014; Noorudheen and
Chandrasekharan, 2016; Santhosh et al., 2016; Sreeshma
et al., 2016; Puthur, 2016).
At present, to our best knowledge, the protective effect of
cyanidin 3-glucoside on diabetic cardiomyopathy in the exper-
imental type 2 diabetic rats is not studied. Therefore, the objec-
tive of present research is to investigate the defensive effects of
cyanidin 3-glucoside on diabetic cardiomyopathy (DCM) and
its underlying mechanism of attenuation in type 2 DM.
2. Materials and methods
2.1. Experimental animals
The current study was carried out with twenty-four male rats
of wistar strain, weighing of 150–200 g. The rats were kept in
a polypropylene laboratory cages, under a maintained environ-
ment of temperature (25 ± 2 C), humidity (50 ± 5%) and
12:12 h light–dark (LD) cycles. They were provided with usual
laboratory food and tap water ad libitum before the experi-
ments. All experimental procedures were carried out as per
standard protocol evaluated and approved by I.A.E.C.
(Institutional animal ethical committee).Please cite this article in press as: Li, W. et al., Potential role of cyanidin 3-glucoside
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The DM in rats was induced by fasting for 12 h. About 65 mg/
kg streptozotocin (STZ) was solubilized in citrate buffer
(0.1 M, pH 4.5) and administered intraperitoneally (i.p.). The
rats were kept again on fasting for 12 h. Streptozotocin was
injected on the 6th day and blood glucose level was determined
by glucometer (Accu-Chek Go model GS; Roche Diagnostics
GmbH, Mannheim, Germany) in entirely collected blood from
the tail vein. Afterward, the rats containing more than 350 mg/
dl glucose level were examined for subsequent studies. The ani-
mals were assigned into three groups as following; Group-1:
Control (n= 8), Group-2: STZ-stimulated DM (n= 8) and
Group-3: DM+ C3G (n= 8). For the Group 3 (DM
+ C3G), 10 mg/kg C3G was solubilized in soybean oil and
then administered orally at same time and each day for 7 days
subsequent to the stimulation of DM.
2.3. Hematological evaluation
After the administration of STZ, levels of blood glucose were
measured in entirely collected blood received from tail vein by
a glucometer (Changsha Sinocare Inc., Changsha, China) at
72 h. The concentrations of total triglyceride (TG) and total
cholesterol (TC) were measured by automatic biochemical
analyzer (Olympus AU2700, Tokyo, Japan). The experimental
rats were euthanized with CO2 inhalation after the 12 days of
C3G treatment. The body weight was noted per day for 7 days.
2.4. Estimation of myocardial enzymes in serum
The samples of blood were obtained by artery of abdomen and
serum was extracted by the centrifugation technique (1600g,
10 min.) at 4 C. The aspartate aminotransferase (AST), cre-
atine kinase (CK) and lactate dehydrogenase (LD) were esti-
mated using the automatic biochemical analyzer (Olympus
AU2700).
2.5. Analysis of SOD enzyme and MDA content
The hearts were isolated from the sacrificed rats, rinsed in iso-
tonic saline and weighed. The myocardial tissues were homog-
enized with 0.1 M phosphate buffer (pH 7.4). The best suited
diagnosis kits A003-1 for MDA content and A004-4 for
SOD activity were obtained from Nanjing Jiancheng Bioengi-
neering Institute (Nanjing, China).
2.6. Immunohistochemical analysis
The paraffin-embedded tissue sections (0.5 lm) were applied
under immunohistochemistry using antigen-retrieval (micro-
wave based) method. The tissue section was incubated using
Anti-IL-6 (#ab6672; 1:500) with primary rabbit polyclonal
Anti-TNF-a (#ab9635; dilution: 1 lg/ml) antibodies (Abcam,
Cambridge, MA, USA) for the overnight, and further incu-
bated with secondary antibody anti-mouse IgG (#7076) and
with biotinylated anti-rabbit (#7074) for half an hour at
37 C. The lesser scanning microscope confocal FV10000
SPD (Olympus) was used to view the results and negative con-
trols were applied as omission of the primary antibody.(C3G) in diabetic cardiomyopathy in diabetic rats: An in vivo approach. Saudi
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The refrigerated samples of tissue from left ventricle were
homogenized with extremely cold lysis buffer tissue (1 mM
Na3VO4, 1% Triton X-100, 1 mM b-glycerophosphate,
20 mM Tris of pH 7.5, 1 mM EDTA, 150 mM NaCl, 1 mM
phenylmethylsulfonyl fluoride, 1 mM EGTA, 2.5 mM sodium
pyrophosphate, 1 mg/ml pepstatin aprotinin and leupeptin) fol-
lowed by centrifugation (1600g, 15 min.) at 4 C. The concen-
tration of protein was examined in supernatant fluid by
utilizing bicinchoninic acid assay (Beyotime Institute of
Biotechnology, Haimen, China). Equivalent quantities of pro-
tein had been utilized for conducting the western blot analysis
in which following antibodies were used; b-actin (#sc-47778;
1:1000; Santa Cruz Biotechnology, Inc., Dallas, TX, USA),
BAX (#2772; 1:1000, Caspase-3 (#9661; 1:1000) with Bcl-2
(#2870; 1:1,000; all from Cell Signaling Technology, Inc.) The
HRP associated secondary antibody had been incubated along
with following membrane for one hour at 37 C. The upgraded
chemiluminescence kit was utilized for producing blots.
2.8. Data analysis
The data obtained from the studies are shown as mean
± SEM. The statistical analysis one-way ANOVA was per-
formed using SPSS15.0 (SPSS, Inc., Chicago, IL, USA), where
statistically significant difference is considered if P< 0.05.
3. Results
3.1. Effects of C3G on metabolic abnormalities
The current hematological studies exhibited the metabolic fea-
tures of the investigational animals. In this experiment, STZ
administered diabetic rats were observed with a significant
(P< 0.05) lower body weight. Additionally, it was found that
STZ injection significantly (P< 0.05) increased the level of
blood glucose and heart-weight to body-weight ratio (HW/
BW) as well as total cholesterol (TC) and total triglycerides
(TG) in diabetic rats, when compared with Group-1(control
group). However, C3G treatments exhibited a notably
increased body weight along with decreased levels of TC, TG
and HW/BW, compared to Group-2(DM group). Also, it
was seen that levels of blood glucose were found significantly
(P< 0.05) lowered (nearly control group) in the DMTable 1 Cyanidin 3-glucoside effects on metabolic dysfunction.
Experimental design Weight of body (g) Heart-weight to body-wei
ratio (HW/BW) (mg/g)
Group-1 (control) 412 ± 14 3.72 ± 0.12
Group-2 (DM) 245 ± 11a 6.23 ± 0.11a
Group-3 (DM+ C3G) 294 ± 23 3.30 ± 0.14
HW/BW ratios were determined on the sacrificed day of rats. The levels o
the sacrificed day. Data are represented as the mean ± SEM.
a P< 0.05, against (Group-1) control group.
b P< 0.05, against diabetic rats (DM group).
Please cite this article in press as: Li, W. et al., Potential role of cyanidin 3-glucoside
Journal of Biological Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.11.007+C3G group as compared with Group-2 (DM group)
(Table 1). These metabolic observations pointed out a good
defensive action of cyanidin 3-glucoside in the DM.
3.2. Effects of C3G on markers of cardiac injury and oxidative
stress
The biochemical marker enzymes of cardiac injury viz. CK,
LD and AST were investigated in the current experiment.
We found that these marker enzymes viz. CK, LD and AST
were significantly (P< 0.05) raised in STZ administered rats
(DM group). While the levels of these elevated marker
enzymes of cardiac injury significantly (P< 0.05) declined in
the DM+ C3G group, as compared to diabetic group of rats
(DM group) (Fig. 1A). These results also indicate a cardiopro-
tective activity of cyanidin 3-glucoside in the diabetic rats. Fur-
thermore, during the cardiac tissue examination, the diabetic
group of rats (DM group) showed a significant (P< 0.05)
decline in the SOD activity and a significant increase of
MDA contents as shown in Fig. 1B and C. Though, C3G
administered to diabetic rats resulted a significant (P< 0.05)
up-regulation of SOD activity and MDA contents, and thus
indicating a potential antioxidant attributes of cyanidin 3-
glucoside.
3.3. C3G inhibits the production of TNF-a and interleukin-6
The expressions of inflammations were measured using
Immunohistochemical technique. The results showed a dense
brown colors staining as a result of increased levels of TNF-
a and interleukin-6 in the STZ administered diabetic rats when
compared to Group-1(control group). While the light colors
staining expressing decrease level of TNF-alpha and
interleukin-6, were noticed in the C3G treated group as com-
pared to diabetic group (Fig. 2). These data indicate a strong
defensive activity of C3G against the mediators of inflamma-
tion produced in DCM.
3.4. C3G prevents DM stimulated apoptosis of myocardial cells
An immunoblotting technique was used for the determination
of expression levels of proteins viz. caspase-3, BAX, and Bcl-2.
The blots demonstrated a lower response of Bcl-2 and higher
response of caspase-3 and BAX in the diabetic group of rats
compared to Group-1(control group). However, C3G treat-ght Blood glucose (mmol/l) Total triglycerides
(TG) (mmol/l)
Total cholesterol
(TC) (mmol/l)
6.4 ± 0.4 0.82 ± 0.04 1.37 ± 0.04
20.6 ± 1.3a 1.34 ± 0.15a 1.721 ± 0.05a
7.2 ± 1.6b 0.87 ± 0.06 1.42 ± 0.30
f TC, TG and blood glucose were determined in fasting basal state on
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Figure 1 Cyanidin 3-glucoside attenuates cardiac damage and oxidative stress in DM. C3G was revealed to (A) reduce cardiac enzyme
release in serum, (B) diminish the MDA content in cardiac tissue and (C) enhance SOD activity.
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Figure 2 C3G inhibits the production of myocardial TNF-a and interleukin-6 expression during Immunohistochemical staining.
Staining of a dense brown color showing the higher inflammatory expression (field of view used at 20 magnification).
Figure 3 Proteins responses of Bcl-2, caspase-3 and BAX in
western blotting. b-Actin control was applied in the experiments.
DM, diabetes mellitus.
Potential role of cyanidin 3-glucoside (C3G) 5ment resulted to higher level response of Bcl-2 and lower level
response of caspase-3 and BAX (Fig. 3).
4. Discussion
Diet is one of the significant factors related with development
of type 2 (Franz et al., 2010). Several experimental findings
indicate that a larger dietary intake of phytochemicals and
polyphenolic compounds containing strong antioxidant capac-
ity could be linked to lowering risk of diabetes as well as pre-
disposing factors (Firdous, 2014). Our hematological finding
revealed that C3G markedly ameliorated the STZ provoked
metabolic abnormalities by increasing the body weight and
decreasing the levels of blood glucose, TC, TG and HW/BW
to closer the normal control rats.Please cite this article in press as: Li, W. et al., Potential role of cyanidin 3-glucoside
Journal of Biological Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.11.007Considerable findings from numerous research of type 1
(Aziz et al., 2013) and type 2 (Singh et al., 2010;
Serasanambati and Chilakapati, 2016) diabetes associate
hyperglycemia which is known as a major clinical marker in
DCM. In this study, higher levels of blood glucose were
observed in the diabetic rats. It is considered that hyper-
glycemia may be possible as a result of reduction of pancreatic
secretion of insulin. It is also well documented that STZ pro-
duced ROS, hinder the antioxidant defense system and causes
oxidative destruction of b-cells in the pancreas (Tonne et al.,
2013). However, increased levels of blood glucose were seen
to be substantially lowered in the C3G treated group, com-
pared to DM group. Though, these levels were not lowered
to the same magnitude compared to control group. Numerous
studies have suggested that dietary supplement plant extracts
rich with C3G are involved with ameliorated insulin sensitivity
in genetic and diet induced animal model of insulin resistance
(Sasaki et al., 2007). Therefore, these metabolic observations
indicate that protective effects of cyanidin 3-glucoside may
be possible due to its ROS scavenging activity in the DM.
The biochemical investigation of marker enzymes of car-
diac injury is usually an important parameter in the diagnosis
of diabetic cardiomyopathy. An augmented level of serum
marker enzymes viz. lactate dehydrogenase (LD), creatine
kinase (CK) and aspartate aminotransferase (AST) leads to
myocardial infarction (Khan et al., 2013). The increased levels
of LD and CK in serum have been reported in the DCM
(Yousaf and Powell, 2012). In this study, C3G significantly
declined the levels of cardiac enzymes such as LD, CK and
AST compared with diabetic rats signifying the cardioprotec-
tive activity of cyanidin 3-glucoside. Oxidative stress provoked
by ROS is a major factor in the DCM etiology (Giacco and
Brownlee, 2010). That the STZ decreases SOD activity and
increases MDA content may be associated with increased for-(C3G) in diabetic cardiomyopathy in diabetic rats: An in vivo approach. Saudi
6 W. Li et al.mations of ROS. Superoxide dismutase (SOD) is a well known
significant defensive antioxidant enzyme which directly elimi-
nates the ROS (Fukai and Ushio-Fukai, 2011). Malondialde-
hyde (MDA), a marker of oxidative stress, is an end product
of lipid peroxidation process. SOD level is declined and
MDA content is raised in the serum of diabetic rats (Desai
et al., 2015). Our finding demonstrated that cyanidin
3-glucoside administered to diabetic rats showed a significant
up-regulation of SOD activity and MDA contents indicating
an efficient ROS scavenging activity.
An increase in pro-inflammatory manifestation is majorly
involved in the development of diabetic cardiomyopathy
(Wang and Cai, 2006). The cytokines such as TNF-a,
interleukin-1beta and interleukin-6 are documented to produce
myocardial injury. TNF-a is well accepted as an important
mediator in heart failure (Tian et al., 2015). It stimulates
inflammatory cytokines and causes myocardial fibrosis and
hypertrophy, subsequently leads to LV dysfunction and
remodeling (Hori and Nishida, 2009).
During the Immunohistochemical analysis, it was found
that C3G remarkably attenuated inflammatory response of
TNF-a and interleukin-6 in the diabetic animals. Thus C3G
is indicating a strong protective activity of C3G against the
inflammation produced in DCM. Furthermore, our
immunoblotting technique showed that C3G treatment
resulted in higher level responses of anti-apoptotic Bcl-2 along
with lower level responses of pro-apoptotic caspase-3 and
BAX (Fig. 3) in the diabetic group. Therefore, C3G amelio-
rated DM stimulated apoptosis of cardiomyocytes and demon-
strating cardioprotective attributes in the diabetes.
5. Conclusion
In summary, cyanidin 3-glucoside demonstrated a beneficial
potential therapeutic agent for the treatment of DCM. Our
finding suggests that cyanidin 3-glucoside, a natural antioxi-
dant may prevents cardiovascular complications by ameliorat-
ing oxidative damage, inflammation, metabolic dysfunctions
and apoptosis pathways in type 2 diabetes.
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